This inventor holds 3 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents. Top assignees: Actelion Pharmaceuticals Ltd, Chemie Linz Aktiengesellschaft. Active years: 1980-2012.
Company Filing History:
Years Active: 1980-2012
Title: Wilhelm Tschebull: Innovator in Pharmaceutical Chemistry
Introduction
Wilhelm Tschebull is a notable inventor based in Linz, Austria. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative processes and compounds. With a total of three patents to his name, Tschebull has demonstrated a commitment to advancing chemical methodologies.
Latest Patents
Tschebull's latest patents include a process for the preparation of an enantiomeric trisubstituted 3,4-dihydro-isoquinoline derivative. This invention involves the hydrogenation of a specific compound using a unique catalyst. Another significant patent is related to a trisubstituted 3,4-dihydro-1H-isoquinolin compound, detailing both its preparation and potential applications.
Career Highlights
Throughout his career, Tschebull has worked with prominent companies such as Actelion Pharmaceuticals Ltd and Chemie Linz Aktiengesellschaft. His work in these organizations has allowed him to develop and refine his innovative ideas in pharmaceutical chemistry.
Collaborations
Tschebull has collaborated with notable colleagues, including Doris Domin and Matthias Helms. These partnerships have likely contributed to the success of his inventions and the advancement of their respective fields.
Conclusion
Wilhelm Tschebull's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the industry and inspire future innovations.